• Press Releases
  • Seno Medical Instruments, Inc. nominates Dr. Robert Kramer to head Scientific Advisory Committee

Newsroom | Press Releases

Seno Medical Instruments, Inc. nominates Dr. Robert Kramer to head Scientific Advisory Committee

SAN ANTONIO, TEXAS—February 26, 2007—Seno Medical Instruments, Inc.,, a San Antonio company engaged in the development of medical devices announces the appointment of Robert I. Kramer, M.D., FAAP to Chairman of its Scientific Advisory Committee.

SENO MEDICAL INSTRUMENTS, INC. Nominates DR. ROBERT KRAMER TO HEAD SCIENTIFIC ADVISORY COMMITTEE

SAN ANTONIO, TEXAS — February 26, 2007 – Seno Medical Instruments, Inc., a San Antonio company engaged in the development of medical devices announces the appointment of Robert I. Kramer, M.D., FAAP to Chairman of its Scientific Advisory Committee. Dr. Kramer, founding member of the Susan G. Komen Advisory Board, is highly regarded for his work in the field of pediatrics and for his support of cancer research and treatment.

Seno Medical Instruments, Inc. was formed in 2005 to commercialize a new modality in cancer screening and diagnosis: opto-acoustic imaging. To further the development of this potentially life-saving technology, the corporation is assembling a team of experts in the field of breast cancer detection, product application and protocol design.

“Dr. Kramer has a deep commitment to the field of breast cancer. He has worked with many early stage companies focused on medical advancement. His extensive experience and knowledge in biotechnology and medical devices is invaluable to us,” said Janet Campbell, Seno Medical CEO. “I feel very fortunate that Dr. Kramer has agreed to assume this responsibility in leading the Advisory Committee.”

Dr. Kramer is a retired professor of pediatrics and pulmonology from UT Southwestern Medical Center in Dallas, Texas. He was the founding medical director of the Division of Pulmonology and Cystic Fibrosis Research Center at the Children’s Medical Center in Dallas. Following his retirement, he became Chairman of the Department of Pediatrics at Baylor University Medical Center. He was the national medical director of the healthcare consulting division of Coopers & Lybrand and in this capacity had his initial introduction to the business of the life science industry. Dr. Kramer is a member of the Board of Directors and Advisory Boards of several early-stage life science companies. He is a member of the External Advisory Committee of the Department of Biomedical Engineering at the University of Texas, Austin.

Dr. Kramer is a native of Rhode Island and a graduate of Tufts University Medical School with a pediatric residency completed at Yale University School of Medicine. He holds an Executive MBA from Harvard Business School.

More Seno Press Releases

Seno Medical® Receives Innovative Technology Contract from Vizient For its Imagio® Breast Imaging System
Contract awarded for products that bring improvement to healthcare industry [SAN ANTONIO, TX – November...
Real World Use of OA Imaging Confirms Clinical Acceptability of Second Generation Imagio® Breast Imaging System
[SAN ANTONIO, TX – October 31, 2024] A study published in Academic Radiology, Exploring the Utility of...
IHE SHARAZONE Hits Major Milestone with 15 Participants, Empowering 37 Creators and 24 Consumers
[May 17, 2024] IHE-Europe is thrilled to report a major milestone for the IHE SHARAZONE, a groundbreaking...
American Medical Association Issues New CPT Code for Use of Seno Medical’s Opto-acoustic Technology in Breast Cancer Diagnosis
CPT Code 0857T Enables a Pathway for Reimbursement When Using Seno’s Imagio® Breast Imaging System to Diagnose...
Seno Medical Earns Frost & Sullivan's 2023 United States Enabling Technology Leadership Award for Delivering a More Efficient Breast Cancer Diagnosis with Its Cutting-edge Technology
Seno Medical offers highly differentiated opto-acoustic/ultrasound (OA/US) exam to diagnose breast cancer...